Armata Pharmaceuticals, Inc. Earnings Per Share Diluted

• Armata Pharmaceuticals, Inc. showed a decrease of -439.3% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Armata Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2013: $0.14 (loss) per share | Q3 2013: $0.44 (loss) per share | Q1 2014: $3.18 (loss) per share | Q2 2014: $0.63 (loss) per share | Q3 2014: $0.86 (loss) per share | Q4 2014: $0.44 (loss) per share | Q1 2015: $3.49 (loss) per share | Q2 2015: $0.33 (loss) per share | Q3 2015: $0.30 (loss) per share | Q4 2015: $0.54 (loss) per share | Q1 2016: $0.82 (loss) per share | Q2 2016: $7.82 (loss) per share | Q3 2016: $3.23 (loss) per share | Q2 2017: $1.46 (loss) per share | Q3 2017: $0.09 (loss) per share | Q2 2018: $0.68 (loss) per share | Q3 2018: $0.60 (loss) per share | Q2 2019: $0.69 (loss) per share | Q3 2019: $0.73 (loss) per share | Q2 2020: $0.26 (loss) per share | Q3 2020: $0.31 (loss) per share | Q1 2021: $0.27 (loss) per share | Q2 2021: $0.25 (loss) per share | Q3 2021: $0.22 (loss) per share | Q1 2022: $0.30 (loss) per share | Q2 2022: $0.26 (loss) per share | Q3 2022: $0.24 (loss) per share | Q1 2023: $0.40 (loss) per share | Q2 2023: $0.17 (loss) per share | Q3 2023: $0.86 (loss) per share | Q1 2024: $0.69 (loss) per share | Q2 2024: $0.25 (loss) per share | Q3 2024: $0.15 (loss) per share | Q1 2025: $0.20 (loss) per share | Q2 2025: $0.45 (loss) per share | Q3 2025: $0.74 (loss) per share.
• Over the full 13 years of available data (2013 to 2025), Armata Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 650.0%.
• Historical annual values: Fiscal year 2025: $4.80 (loss) per share | Fiscal year 2024: $0.89 (loss) per share | Fiscal year 2023: $1.91 (loss) per share | Fiscal year 2022: $1.08 (loss) per share | Fiscal year 2021: $0.96 (loss) per share | Fiscal year 2020: $1.35 (loss) per share | Fiscal year 2019: $2.55 (loss) per share | Fiscal year 2018: $3.59 (loss) per share | Fiscal year 2017: $2.18 (loss) per share | Fiscal year 2016: $24.67 (loss) per share | Fiscal year 2015: $1.99 (loss) per share | Fiscal year 2014: $2.33 (loss) per share | Fiscal year 2013: $0.64 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026